Doximity, Inc.

Doximity, Inc.

32.51
USD
-0.67
(-2.02%)
0.85EPS
23.05P/E
3.73BMarket Cap
Feb 11Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.57
0.77
1.16
2.1
2.17
2.5
3.05
3.45
3.53
Basic EPS, GAAP
0.05
0.2
0.28
0.95
0.58
0.78
1.19
1.05
0.9
Free Cash Flow per Basic Share
0.1
0.15
0.44
0.74
0.9
0.94
1.43
1.7
1.6
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
0.37
4.57
4.98
4.83
5.73
5.19
5.09
Tangible Book Value per Share
- -
- -
0.21
4.43
4.47
4.32
5.25
4.54
4.44
Basic Weighted Avg Shares
151
151
178
163
193
190
187
187
186
Sales/Revenue/Turnover
86
116
207
344
419
475
570
645
656
Operating Margin (%)
8.08
19.04
25.76
33.05
29.86
36.14
40.34
33.33
29.6
Depreciation Expense
1
1
4
5
10
10
11
14
16
Net Income, GAAP
8
30
50
155
113
148
223
196
167
Effective Tax Rate (%)
1.24
- -
13.08
- -
15.27
20.31
15.32
21.58
26.16
Profit Margin (%)
9.14
25.55
24.27
45.05
26.92
31.04
39.13
30.4
25.48
Working Capital
- -
67
107
793
836
766
932
789
764
LT Debt
- -
- -
- -
- -
14
12
10
8
8
Total Equity
- -
1
67
879
966
901
1,083
951
916
Return on Invested Capital (%)
- -
- -
132.61
- -
11.38
13.67
19.07
16.36
14.48
Return on Capital (%)
- -
- -
140.61
- -
12.12
15.55
22.2
19.07
17.02
Return on Common Equity (%)
- -
- -
147.94
32.75
12.23
15.81
22.5
19.28
17.21

Capital Structure

USD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
9
8
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
185
183
180
Market Capitalization
8,191
4,265
3,730

Working Capital

USD

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
993
944
914
Cash, Cash Equivalents & STI
735
749
688
Accounts Receivable, Net
157
145
178
Inventories
- -
- -
- -
Total Current Liabilities
150
155
150
Payables & Accruals
67
32
33
ST Debt
2
2
2
Deferred Revenue
66
106
109

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
245.52%
-12.17%
Free Cash Flow
- -
33.83%
19.03%
Net Income, GAAP
- -
50.21%
-12.16%
Sales/Revenue/Turnover
- -
26.9%
13.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
127
137
169
138
570
2026
146
169
185
145
645
2027
157
- -
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.22
0.24
0.4
0.33
1.19
2026
0.28
0.33
0.33
0.1
1.05
2027
0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Jeffrey A. Tangney
Full Time Employees
880
Sector
Technology services
Industry
Packaged software
Address
500, 3rd Street San Francisco CA United States 94107
IPO Date
Jun 24, 2021
Business
I will refine the search specifically for latest major company changes for Doximity, Inc. to find accurate and recent updates.

Company News

  • DOCS DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Encourages Doximity, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS

  • DOCS Deadline: Rosen Law Firm Urges Doximity, Inc. (NYSE: DOCS) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights

  • Doximity Q2 Earnings Call Highlights

  • DOCS DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS

  • Doximity, Inc. (DOCS) Q2 2027 Earnings Call Transcript

  • DOCS FINAL DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – DOCS

  • DOCS Class Action Lead Plaintiff Deadline is November 16, 2026 - Contact Robbins LLP About Leading the Case Against Doximity, Inc.

  • DOCS INVESTOR DEADLINE: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline

  • DOCS DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action - DOCS

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS

  • DOCS Deadline: DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit

  • Compared to Estimates, Doximity (DOCS) Q2 Earnings: A Look at Key Metrics

  • Doximity (DOCS) Beats Q2 Earnings and Revenue Estimates

  • Kaplan Fox Advises Investors of Doximity, Inc. (DOCS) of an Upcoming Securities Class Action Deadline on November 16, 2026

  • DOCS INVESTOR ALERT: Bragar Eagel & Squire, P.C. Urges Doximity, Inc. Investors to Contact the Firm Before November 16th Lead Plaintiff Deadline

  • DOCS INVESTOR ALERT: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline - RGRD Law

  • Doximity Announces Fiscal 2027 Second Quarter Financial Results

  • Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • DOCS Investor Alert: Doximity, Inc. Securities Class Action Notice - Contact SueWallSt

  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law